AlphAIalphai — Financial news for AI agents
Stock TitanAPR 12 min read$RAPP

Rapport Therapeutics (RAPP) COO sells 10,000 shares under Rule 10b5-1 plan

Rapport Therapeutics' COO, Cheryl Gault, sold 10,000 shares of common stock in open-market transactions on March 30, 2026, under a pre-arranged Rule 10b5-1 trading plan adopted on December 10, 2025. The sales were conducted in two tranches at weighted average prices of $28.0401 and $28.5530, totaling approximately $281,857. Following these transactions, Gault directly holds 159,914 shares.

Original reporting
Stock Titan
Published Apr 1, 2026, 3:09 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Apr 1, 2026, 3:31 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
Rapport Therapeutics (RAPP) COO sells 10,000 shares under Rule 10b5-1 plan — source image
Source · Stock Titan
Decision brief

The 30-second read

$RAPPNeutralLow
01

Why it matters

While insider sales can sometimes signal lack of confidence, in this case, it appears routine. No immediate fundamental concerns are indicated.

02

Market read

The insider sale is a company-specific event with limited broader market implications.

03

What to watch

Lack of information on the company's recent financial performance or upcoming catalysts; insider sales might be scheduled or unrelated to company outlook.

Timing: short-term

Background

Rapport Therapeutics is a biotech company focused on neurological disorders. The COO's sale occurred on March 30, 2026, under a pre-arranged plan.

Company-level read

Ticker impact

$RAPPNeutralMedium confidence
Context

The insider trading activity of Rapport Therapeutics (RAPP) COO may indicate internal confidence or concerns about the company's near-term prospects.

Expected impact

Limited immediate impact; potential slight bearish sentiment in short term.

Evidence & confidence

Insider sales under Rule 10b5-1 plans are common and can be scheduled; without additional context, the impact on stock price remains uncertain.

Market effects

Sector

Minimal sector impact; insider sales are company-specific.

Regional

Negligible regional effects.

Global

Low; company-specific event.

Counterpoint

What could challenge this read

Insider sales may be routine and not indicative of future performance; could be personal liquidity event.

Key entities

  • Person
    Cheryl Gault

    Chief Operating Officer of Rapport Therapeutics.

  • Company
    Rapport Therapeutics

    Biotech company specializing in neurological disorder treatments.

Read at source← All news

Related articles

AUG 5
$RAPPMed

Rapport Therapeutics, Inc. (RAPP): Results of Operations and Financial Condition

Rapport Therapeutics, Inc. (RAPP) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 rapp-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Rapport Therapeutics Reports Second Quarter 2026 Financials and Provides Business Update RAP-219 Phase 3 program in focal onset seizures initiated, with FOCUS 1 and FOCUS 2 trials enrolling patients RAP-219 Phase 2 trial in b

SEC EDGAR 8-K6 min
AUG 8
$BKRMed

Baker Hughes extends long-term service deal for Nigeria LNG Train 7

Baker Hughes said it won a 13-year lifecycle services deal with Nigeria LNG for turbomachinery at NLNG’s Train 7 expansion on Bonny Island. The scope covers heavy-duty gas turbines, centrifugal compressors, remote monitoring via Baker Hughes’ digital platform, and local support. Train 7 is expected to raise capacity from 22 to 30 MMtpa.

worldoil.com3 min
AUG 8
$BKRMed

Baker Hughes wins subsea systems contract for Angola's Greater PAJ field

Baker Hughes said it won a contract from Azule Energy to supply subsea production systems for the Greater PAJ ultra-deepwater project offshore Angola. Scope includes horizontal subsea trees, control modules, workover control systems and related equipment plus installation and support. Greater PAJ is expected to start producing in 2029 via an FPSO processing up to 95,000 bpd, with deliveries starting in 2027.

worldoil.com4 min
AUG 8
$WENMed

57-year-old Burger chain closed 28 restaurants, 100s more coming

Wendy’s (WEN) said it closed 28 restaurants and expects to close 5% to 6% of U.S. units (about 289 to 358) in 1H 2026, with possible additional selective closures. The company reported 2Q FY2026 systemwide sales down 6.5% YoY, U.S. systemwide down 8.2%, and U.S. same-restaurant sales down 7%. Wendy’s launched a turnaround plan and withdrew its 2026 outlook.

yahoo.com6 min
AUG 8
$ACIMed

Albertsons recalls ready-to-eat items in multiple states amid salmonella-linked jalapeño investigation

Albertsons Companies said it is voluntarily recalling four ready-to-eat products containing jalapeños supplied by Taylor Farms, including items sold at Randalls in Texas. The recall followed a supplier recall tied to an ongoing federal investigation and an FDA probe of a Salmonella Javiana outbreak. FDA reported 345 illnesses in 27 states, 36 hospitalizations, no deaths.

click2houston.com5 min